These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inability of carbenicillin to predict ticarcillin activity versus Pseudomonas aeruginosa by disc-agar diffusion. Flournoy DJ. Methods Find Exp Clin Pharmacol; 1982; 4(2):119-20. PubMed ID: 6811811 [No Abstract] [Full Text] [Related]
25. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin. Monif GR, Clark PR, Shuster JJ, Baer H. Antimicrob Agents Chemother; 1978 Nov; 14(5):643-9. PubMed ID: 103491 [Abstract] [Full Text] [Related]
32. Comparative "in vitro" activity of pirbenicillin and carbenicillin against clinical and environmental "Pseudomonas aeruginosa" isolates from hospitals. Castellani Pastoris M, Mondello F, Gennaro ML, Greco D. Ann Sclavo; 1980 Sep; 22(6):931-9. PubMed ID: 6794465 [No Abstract] [Full Text] [Related]
33. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications. Dulong de Rosnay HL, Grimont PA, Dessaut B, Lesgouarres MT. J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279 [Abstract] [Full Text] [Related]
34. Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin. Phaneuf D, Neu HC. Antimicrob Agents Chemother; 1979 Nov; 16(5):625-30. PubMed ID: 118706 [Abstract] [Full Text] [Related]
35. Laboratory studies with a new broad-spectrum penicillin, pirbenicillin. Retsema JA, English AR, Lynch JE. Antimicrob Agents Chemother; 1976 Jun; 9(6):975-82. PubMed ID: 938027 [Abstract] [Full Text] [Related]
36. In vitro activity of carbenicillin, ticarcillin, aminoglycosides and combinations against Staphylococcus aureus. Watanakunakorn C, Glotzbecker C. J Antimicrob Chemother; 1979 Mar; 5(2):151-8. PubMed ID: 429247 [No Abstract] [Full Text] [Related]
37. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams]. Thabaut A, Meyran M. Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939 [Abstract] [Full Text] [Related]
38. The in vitro activity of beta-lactam antibiotics against gentamicin and/or carbenicillin-resistant Pseudomonas aeruginosa strains. Aisa ML, Omenaca M, Bergua C, Garcia-Moya JB. Infection; 1982 May; 10 Suppl 3():S244-8. PubMed ID: 6818157 [Abstract] [Full Text] [Related]
39. Resistant strains of Pseudomonas aeruginosa isolated after exposure to several beta-lactam antibiotics. Hoekstra JL, de Neeling AJ, van Klingeren V, Stobberingh EE, van Boven CP. Eur J Clin Microbiol; 1987 Feb; 6(1):22-7. PubMed ID: 3106033 [Abstract] [Full Text] [Related]
40. ["In vitro" activity of a new cephalosporin (CGP-7174-E or cefsulodin) against "Pseudomonas aeruginosa" (author's transl)]. Berche P, Descamps P, Avril JL, Véron M. Ann Microbiol (Paris); 1979 Feb; 130B(4):477-84. PubMed ID: 120122 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]